238 related articles for article (PubMed ID: 22454771)
21. Structural and functional insights into the interaction of sulfated glycosaminoglycans with tissue inhibitor of metalloproteinase-3 - A possible regulatory role on extracellular matrix homeostasis.
Rother S; Samsonov SA; Hofmann T; Blaszkiewicz J; Köhling S; Moeller S; Schnabelrauch M; Rademann J; Kalkhof S; von Bergen M; Pisabarro MT; Scharnweber D; Hintze V
Acta Biomater; 2016 Nov; 45():143-154. PubMed ID: 27545813
[TBL] [Abstract][Full Text] [Related]
22. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion.
Ramos-DeSimone N; Hahn-Dantona E; Sipley J; Nagase H; French DL; Quigley JP
J Biol Chem; 1999 May; 274(19):13066-76. PubMed ID: 10224058
[TBL] [Abstract][Full Text] [Related]
23. Expression pattern and functional studies of matrix degrading proteases and their inhibitors in the mouse corpus luteum.
Liu K; Wahlberg P; Hägglund AC; Ny T
Mol Cell Endocrinol; 2003 Jul; 205(1-2):131-40. PubMed ID: 12890575
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase-2: A key regulator in coagulation proteases mediated human breast cancer progression through autocrine signaling.
Das K; Prasad R; Ansari SA; Roy A; Mukherjee A; Sen P
Biomed Pharmacother; 2018 Sep; 105():395-406. PubMed ID: 29870887
[TBL] [Abstract][Full Text] [Related]
25. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
26. Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.
Skrzydlewska E; Sulkowska M; Koda M; Sulkowski S
World J Gastroenterol; 2005 Mar; 11(9):1251-66. PubMed ID: 15761961
[TBL] [Abstract][Full Text] [Related]
27. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
Montgomery N; Hill A; McFarlane S; Neisen J; O'Grady A; Conlon S; Jirstrom K; Kay EW; Waugh DJ
Breast Cancer Res; 2012 May; 14(3):R84. PubMed ID: 22621373
[TBL] [Abstract][Full Text] [Related]
28. Recruitment of Matrix Metalloproteinase-9 (MMP-9) to the Fibroblast Cell Surface by Lysyl Hydroxylase 3 (LH3) Triggers Transforming Growth Factor-β (TGF-β) Activation and Fibroblast Differentiation.
Dayer C; Stamenkovic I
J Biol Chem; 2015 May; 290(22):13763-78. PubMed ID: 25825495
[TBL] [Abstract][Full Text] [Related]
29. PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma.
Freytag J; Wilkins-Port CE; Higgins CE; Carlson JA; Noel A; Foidart JM; Higgins SP; Samarakoon R; Higgins PJ
J Oncol; 2009; 2009():963209. PubMed ID: 20204159
[TBL] [Abstract][Full Text] [Related]
30. Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade.
Le DM; Besson A; Fogg DK; Choi KS; Waisman DM; Goodyer CG; Rewcastle B; Yong VW
J Neurosci; 2003 May; 23(10):4034-43. PubMed ID: 12764090
[TBL] [Abstract][Full Text] [Related]
31. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
32. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.
Ottaviano AJ; Sun L; Ananthanarayanan V; Munshi HG
Cancer Res; 2006 Jul; 66(14):7032-40. PubMed ID: 16849548
[TBL] [Abstract][Full Text] [Related]
33. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS
Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266
[TBL] [Abstract][Full Text] [Related]
34. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
[TBL] [Abstract][Full Text] [Related]
35. Spatial and temporal pattern of expression of interstitial collagenase, stromelysin/transin, gelatinase A, and TIMP-1 during experimental gastric ulcer healing.
Calabrò A; Grappone C; Pellegrini G; Evangelista S; Tramontana M; Schuppan D; Herbst H; Milani S
Digestion; 2004; 70(2):127-38. PubMed ID: 15375341
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression.
Sun L; Diamond ME; Ottaviano AJ; Joseph MJ; Ananthanarayan V; Munshi HG
Mol Cancer Res; 2008 Jan; 6(1):10-20. PubMed ID: 18234959
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
[TBL] [Abstract][Full Text] [Related]
38. MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1.
Tatti O; Vehviläinen P; Lehti K; Keski-Oja J
Exp Cell Res; 2008 Aug; 314(13):2501-14. PubMed ID: 18602101
[TBL] [Abstract][Full Text] [Related]
39. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.
Cher ML; Biliran HR; Bhagat S; Meng Y; Che M; Lockett J; Abrams J; Fridman R; Zachareas M; Sheng S
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7847-52. PubMed ID: 12788977
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
